Brokerage Mirae Asset Sharekhan has suggested buying five stocks from a long-term perspective. According to the analysts, ...
JPMorgan is sticking with Eli Lilly (LLY) as its top biopharma pick for 2025, while also highlighting Gilead Sciences (GILD) and Bristol Myers Squibb (BMY) as stocks with potential upside, according ...